Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 207 publications
Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study.
Journal: Focus (American Psychiatric Publishing)
Published: August 01, 2026
Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study.
Journal: Focus (American Psychiatric Publishing)
Published: August 01, 2026
Efficacy and Safety of the Selective, Brain-Penetrant P2X7 Receptor Antagonist JNJ-55308942 (Zanvipixant) in Bipolar Depression: A Phase 2a Study.
Journal: Biological psychiatry global open science
Published: January 27, 2026
Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study.
Journal: The international journal of neuropsychopharmacology
Published: November 03, 2025
Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
Journal: The American journal of psychiatry
Published: October 01, 2025
Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science.
Journal: Clinical and translational science
Published: September 30, 2025
Efficacy and safety of adjunctive treatment with the fatty acid amide hydrolase inhibitor JNJ-42165279 in participants with major depressive disorder with anxious distress: A double-blind, placebo-controlled, randomised study.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: August 22, 2025
Efficacy and Safety of Seltorexant in Insomnia Disorder: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: August 13, 2025
Biomarker innovations in precision psychiatry diagnostics and treatment strategies.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: July 11, 2025
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: July 02, 2025
Clinical outcomes of youth at familial risk for bipolar disorder: A 2-year longitudinal, observational study.
Journal: Journal of affective disorders
Published: May 19, 2025
The Future of Immunotherapies for Mental Illness: A Precision Medicine Perspective.
Journal: Biological psychiatry
Published: March 17, 2025
Last Updated: 09/26/2026